Covered recipient · General Payments record
THOMAS MICHAEL MEIRICK
Allopathic & Osteopathic Physicians Ophthalmology Cornea and External Diseases Specialist
General Payments · PY2023–2024
$2,393.70
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,089.92 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $725.64 | 13 |
| RxSight Inc | $549.18 | 7 |
| Dompe US, Inc. | $362.84 | 8 |
| GLAUKOS CORPORATION | $180.57 | 2 |
| Amgen Inc. | $121.73 | 1 |
| Bausch & Lomb Americas Inc. | $107.79 | 3 |
| Sight Sciences, Inc. | $42.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $12.67 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718111 | CMS |
| Alcon Vision LLC | $14.34 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718113 | CMS |
| Alcon Vision LLC | $73.59 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718125 | CMS |
| Alcon Vision LLC | $23.34 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718117 | CMS |
| Alcon Vision LLC | $26.47 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718119 | CMS |
| Alcon Vision LLC | $138.52 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718131 | CMS |
| Alcon Vision LLC | $46.10 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718123 | CMS |
| Alcon Vision LLC | $8.46 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718109 | CMS |
| Alcon Vision LLC | $39.36 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718121 | CMS |
| Alcon Vision LLC | $109.35 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718129 | CMS |
| Alcon Vision LLC | $73.90 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718127 | CMS |
| Alcon Vision LLC | $144.88 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718133 | CMS |
| Alcon Vision LLC | $14.66 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718115 | CMS |
| Amgen Inc. | $121.73 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115925606 | CMS |
| Bausch & Lomb Americas Inc. | $19.40 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140459492 | CMS |
| Bausch & Lomb Americas Inc. | $71.19 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140459494 | CMS |
| Bausch & Lomb Americas Inc. | $17.20 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140459490 | CMS |
| Dompe US, Inc. | $54.96 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417275 | CMS |
| Dompe US, Inc. | $40.50 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417285 | CMS |
| Dompe US, Inc. | $10.01 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417277 | CMS |
| Dompe US, Inc. | $110.29 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417283 | CMS |
| Dompe US, Inc. | $25.00 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417279 | CMS |
| Dompe US, Inc. | $82.74 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417281 | CMS |
| Dompe US, Inc. | $13.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417273 | CMS |
| Dompe US, Inc. | $25.37 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417287 | CMS |
| Glaukos Corporation | $153.25 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151979228 | CMS |
| Glaukos Corporation | $27.32 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151989830 | CMS |
| RxSight Inc | $16.47 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222028 | CMS |
| RxSight Inc | $179.02 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222030 | CMS |
| RxSight Inc | $163.19 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222032 | CMS |
| RxSight Inc | $37.08 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222034 | CMS |
| RxSight Inc | $20.03 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222036 | CMS |
| RxSight Inc | $109.48 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222038 | CMS |
| RxSight Inc | $23.91 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222040 | CMS |
| Sight Sciences, Inc. | $42.17 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931401 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.